Search

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

We are actively recruiting graduate students with interests in computational biology, single-cell genomics, immunotherapy, and/or molecular genetics.

A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA.

Scientific Advisor, Celmatix, New York, NY

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.